trending Market Intelligence /marketintelligence/en/news-insights/trending/fVQltE_kkefcCkuKu2IJHw2 content esgSubNav
In This List

Praesidian Capital adds genetic medicine services company to portfolio

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Praesidian Capital adds genetic medicine services company to portfolio

Praesidian Capital bought a clinical and laboratory services company focused on genetic medicine, marking its first acquisition as an independent sponsor.

The genetics business specializes in the prenatal and preconception field and provides hereditary cancer-risk tests.

The private investment firm targets lower-middle-market companies in the U.S., U.K., Germany and select Northern European businesses.